묘사

Jones Lang LaSalle Americas, Inc. (“JLL”), as exclusive representative for the Seller, is pleased to present this offering for the sale of 350 George Patterson (the “Property”), a 100% leased, mission-critical specialty chemicals research and development facility. The 71,500 SF building is fully leased to investment grade tenant Syensqo on a triple net basis with nine years of firm term remaining following a recent lease renewal, highlighting the tenant’s long-term commitment to the site.

Syensqo (EBR: SYENS) is a premier Belgian publicly traded specialty chemicals and advanced materials leader. The company develops high-performance chemical solutions for vital global industries, including healthcare, electronics, and automotive. 350 George Patterson serves as a vital research and process development center for Syensqo’s Performance & Care segment, supporting the global Novecare business unit.

The Property is strategically situated in Bristol, Pennsylvania, within the premier commercial and industrial corridor of the Greater Philadelphia region. Located in the Bridge Business Center, the Property occupies a highly accessible location between Philadelphia and the New Jersey research corridors providing Syensqo central access to key industry constituents and clients. Immediate proximity to I-95 and the PA Turnpike provides seamless logistics and connects the site to a dense regional talent pool of over 55,000 scientific, engineering, and technical professionals.

350 George Patterson presents a rare opportunity to acquire a specialized R&D and laboratory asset backed by a triple net (“NNN”) lease with a world-class global chemistry and advanced materials leader.

...

개요

건물 총면적

6,643 제곱미터

점유율

100%

월트

9 년

거주자

미디어

투자 하이라이트

Mission-Critical Facility: Serves As A Vital Research Hub For Syensqo’s Performance & Care Segment And Is One Of Syensqo’s Four Dedicated Research & Innovation Centers In The United States
Entrenched Investment Grade Tenancy: Leased To Syensqo (S&P: BBB), A Global Specialty Chemicals Leader With A 20+ Year Operational History At The Property, Further Validated By Their Recent Lease Renewal
Long Term NNN Cash Flow: 100% Leased On A Triple-Net Basis With Nine Years Of Remaining Term, Providing $16.5 MM ($230 PSF) Of Contractual Cash Flow Through Tenant’s Dec-35 Expiration
High-Barrier-To-Entry Asset: Highly Specialized 71,500 SF Specialty Research And Process Development Facility Featuring Advanced Synthesis, Microbiology, And Analytical Laboratories
Unrivaled Connectivity: Exceptionally Located In The Bridge Business Center With Immediate Access To I-95 And The PA Turnpike, Providing Syensqo Proximity To Key Industry Constituents And Clients